Dengue is an emerging disease of major global significance and represents an enormous burden for health care systems in endemic countries. Differentiating dengue from other common febrile illnesses before complications develop is difficult - simple and inxpensive strategies are urgently needed to support early and accurate diagnosis, as well as to identify patients at high risk of developing complications, in order both to improve case management and to facilitate appropriate use of limited resources.
In the IDAMS project a consortium of international experts work together to develop new and innovative tools to be applied to the control of dengue in a global context and aims at:improving diagnosis and clinical management of dengue through two linked work packages designed a) to identify readily available clinical and laboratory parameters and/or viral and immunological markers, that differentiate between dengue and other common febrile illness within 3 days of fever onset, and b) to identify any of the available markers that are predictive of the likelihood of evolving to a more severe disease course
LSTM collaboratin is led by Dr. Philip McCall
